Altered Nasal Microbiota in Sinonasal Tumors: A Comparative Analysis of Malignant and Benign Sinonasal Tumors
Open Access
- 20 February 2026
- journal article
- Published by Wiley in International Forum of Allergy & Rhinology
- Vol. 16 (8) , 778-787
Abstract
Background: Although shifts in nasal microbiota have been well‐documented in inflammatory upper airway conditions, microbiota tumor‐associated alterations remain uncharacterized. This study is the first to compare sinonasal microbiota profiles of patients with malignant tumors (MT), benign tumors (BT), and controls, offering insights into tumor‐associated microbiomes. Methods: This prospective, cross‐sectional, observational study assessed intraoperative sinus swabs from 70 adult research participants (MT = 23, BT = 15, control = 32). Sinonasal microbial communities were characterized using 16S rRNA gene amplicon sequencing to determine if microbial community structures differed between groups. Results: Tumor‐associated sinonasal microbiota profiles showed clear dysbiosis, with reduced relative abundance of beneficial microbes and increased putative pathogenic taxa. Both MT and BT had significantly lower microbial diversity and distinct compositions compared to controls. MT samples had significantly higher relative abundance of Firmicutes and reduced relative abundance of Actinobacteria. These phylum‐level alterations were accompanied by elevated proinflammatory microbial taxa, paired with reduced relative abundance of keystone, beneficial taxa consistent with healthy nasal microbiomes. Microbial communities in BT and MT samples were similar, but Alcaligenes was more abundant, and Corynebacterium was less abundant in MT than in BT. Conclusion: This study observed that sinonasal microbial communities in MT exhibited marked dysbiosis with a reduction in the relative abundance of putative sinonasal commensal taxa compared to controls. These alterations were present to a lesser extent in BT. Future investigations should aim to determine whether these microbial shifts contribute to tumor development or represent secondary effects, with an aim to quantify their impact on outcomes and guide therapeutic strategies.Keywords
This publication has 34 references indexed in Scilit:
- Gut microbiome dysbiosis is associated with lumbar degenerative spondylolisthesis in symptomatic patientsJOR SPINE, 2024
- Commensal microbe regulation of skin cells in diseaseCell Host & Microbe, 2024
- Increased antibiotic resistance of Pseudomonas aeruginosa isolates from chronic rhinosinusitis patients grown in anaerobic conditionsLaryngoscope Investigative Otolaryngology, 2024
- Longitudinal characterization of the tumoral microbiome during radiotherapy in HPV-associated oropharynx cancerClinical and Translational Radiation Oncology, 2021
- A rare case of polymicrobial chronic maxillary sinusitis due to concurrent isolation of Parvimonas micra and Fusobacterium nucleatumAnaerobe, 2020
- The role of Fusobacterium nucleatum in colorectal cancer: from carcinogenesis to clinical managementChronic Diseases and Translational Medicine, 2019
- The Microbiome and Genitourinary Cancer: A Collaborative ReviewEuropean Urology, 2019
- Making and Sequencing Heavily Multiplexed, High-Throughput 16S Ribosomal RNA Gene Amplicon Libraries Using a Flexible, Two-Stage PCR Protocol2018
- Paranasal sinus cancerCritical Reviews in Oncology/Hematology, 2016
- Different clinical factors associated with Staphylococcus aureus and Pseudomonas aeruginosa in chronic rhinosinusitisInternational Forum of Allergy & Rhinology, 2015